1. Home
  2. CRVS vs MIY Comparison

CRVS vs MIY Comparison

Compare CRVS & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • MIY
  • Stock Information
  • Founded
  • CRVS 2014
  • MIY 1992
  • Country
  • CRVS United States
  • MIY United States
  • Employees
  • CRVS N/A
  • MIY N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • MIY Investment Bankers/Brokers/Service
  • Sector
  • CRVS Health Care
  • MIY Finance
  • Exchange
  • CRVS Nasdaq
  • MIY Nasdaq
  • Market Cap
  • CRVS 305.4M
  • MIY 322.1M
  • IPO Year
  • CRVS 2016
  • MIY N/A
  • Fundamental
  • Price
  • CRVS $5.55
  • MIY $11.18
  • Analyst Decision
  • CRVS Strong Buy
  • MIY
  • Analyst Count
  • CRVS 4
  • MIY 0
  • Target Price
  • CRVS $15.00
  • MIY N/A
  • AVG Volume (30 Days)
  • CRVS 461.1K
  • MIY 56.8K
  • Earning Date
  • CRVS 08-07-2025
  • MIY 01-01-0001
  • Dividend Yield
  • CRVS N/A
  • MIY 3.98%
  • EPS Growth
  • CRVS N/A
  • MIY N/A
  • EPS
  • CRVS N/A
  • MIY N/A
  • Revenue
  • CRVS N/A
  • MIY N/A
  • Revenue This Year
  • CRVS N/A
  • MIY N/A
  • Revenue Next Year
  • CRVS N/A
  • MIY N/A
  • P/E Ratio
  • CRVS N/A
  • MIY N/A
  • Revenue Growth
  • CRVS N/A
  • MIY N/A
  • 52 Week Low
  • CRVS $2.54
  • MIY $9.45
  • 52 Week High
  • CRVS $10.00
  • MIY $11.70
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 69.70
  • MIY 57.36
  • Support Level
  • CRVS $5.03
  • MIY $10.97
  • Resistance Level
  • CRVS $5.81
  • MIY $11.31
  • Average True Range (ATR)
  • CRVS 0.32
  • MIY 0.12
  • MACD
  • CRVS 0.09
  • MIY -0.01
  • Stochastic Oscillator
  • CRVS 85.22
  • MIY 55.26

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About MIY Blackrock MuniYield Michigan Quality Fund Inc.

Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.

Share on Social Networks: